Karen Clise-Dwyer

The University of Texas MD Anderson Cancer Center — United States

Immunology and Microbiology · Life Sciences

33h-index4.9kcitations211works5.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(56), CAR-T cell therapy research(36), Acute Myeloid Leukemia Research(32), Multiple Myeloma Research and Treatments(30), Monoclonal and Polyclonal Antibodies Research(30)

Publications211 total

Mechanistic approach exploring combination agents to potentiate anti-leukemia activity of Hu8F4, a clinical stage T cell receptor mimic antibody
Blood·2025Open Access
IMMU-91. Ligand receptor analyses of glioma immune microenvironment identifies Galectin-9 in microglia as regulator of tumor cell adhesion and phagocytosis
Neuro-Oncology·2025Open Access
FLASH radiotherapy spares lymphocytes in tumor-draining lymph nodes and increases infiltration of immune cells in tumors
2025Open Access
Natural killer cells’ functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes
Nature Communications·2025· 4 citedOpen Access
Evolution of chronic lymphocytic leukemia after allogeneic stem cell transplant
2025Open Access
Cord-Derived Invariant Natural Killer T Cells As Novel Cell Therapy to Improve the Outcome of Hematopoietic Stem Cell Transplantation
Blood·2024Open Access
The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia
Blood Cancer Journal·2024· 7 citedOpen Access
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas
Neuro-Oncology·2024· 12 citedOpen Access
Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo
Cytotherapy·2024· 2 citedOpen Access
Abstract 44: A novel, codon-based method to modulate off-tumor toxicity of chimeric antigen receptor (CAR) T cells
Cancer Research·2024
STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response
Leukemia·2024· 4 citedOpen Access
Hu8F4-CAR T cells with mutated Fc spacer segment improve target-specificity and mediate anti-leukemia activity in vivo
2024Open Access
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
Neuro-Oncology·2024· 46 citedOpen Access
Phase I Study of the T-Cell Receptor-like Antibody, Hu8F4 in Patients with Relapsed and Refractory Myeloid Malignancies
Blood·2023
CD47 Blockade Enhances Phagocytic Activity of the TCR-Mimic Antibody Hu8F4 Against HLA-A2+ AML
Blood·2023· 1 citedOpen Access
IL-1β–mediated inflammatory signaling drives ineffective erythropoiesis in early-stage myelodysplastic syndromes
2023Open Access
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
2023· 9 citedOpen Access
Supplementary Data from Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in <i>SF3B1</i>-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts
2023Open Access
Supplementary Figures from Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia
2023Open Access
Data from Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in <i>SF3B1</i>-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Gheath Alatrash(20), Jeffrey J. Molldrem(19), Lisa S. St. John(14), Kathryn Ruisaard(13), Pariya Sukhumalchandra(12), Qing Ma(12), Sijie Lu(11), Elizabeth A. Mittendorf(9), Анна Сергеева(8), Anne V. Philips(7), Na Qiao(7), Hong He(6), Céline Kerros(6), Jason Roszik(5), Luigi Nezi(5), Jennifer A. Wargo(5), Haven R. Garber(5), Michael Andreeff(5), Guillermo Garcia‐Manero(5), Adi Diab(4)